KBFS
CLB icon

Kohmann Bosshard Financial Services’s Core Laboratories CLB Stock Holding History

Kohmann Bosshard Financial Services’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11
Closed -$190 – 376
2024
Q4 		$190 Buy
+11
New +$212 ﹤0.01% 727

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $4.89B AUM 33.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Kohmann Bosshard Financial Services's CLB Position: Q1 2025 in Review

Kohmann Bosshard Financial Services sold out of Core Laboratories (CLB) in Q1 2025, closing a stake of 11 shares — an estimated $190 sold.

Kohmann Bosshard Financial Services first reported a position in CLB in Q4 2024 and held it in 1 quarter. The position peaked at $190 in Q4 2024. 195 funds tracked by Wall St. Rank hold CLB as of Q1 2025.

  • Kohmann Bosshard Financial Services reported no remaining Core Laboratories position as of Q1 2025 after selling out during the quarter.
  • Kohmann Bosshard Financial Services sold 11 Core Laboratories shares in Q1 2025, an estimated $190.
  • Kohmann Bosshard Financial Services first reported a position in Core Laboratories in Q4 2024 and held it in 1 quarter.
  • Kohmann Bosshard Financial Services's Core Laboratories position peaked at $190 in Q4 2024.
  • 195 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2025.

Based on Kohmann Bosshard Financial Services's 13F filing for Q1 2025, filed 12 May 2025.